Frontier IP (FIPP) AI Stock Analysis

• Market Cap: £10.21M
• Dividend Yield: N/A
• Average Volume (3M): 109.26K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.88
• Revenue Growth: -9.22%
• EPS Growth: -386.93%
• Country: UK
• Employees: 21
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): -0.07
• Shares Outstanding: 75,638,240
• 10 Day Avg. Volume: 41,574
• 30 Day Avg. Volume: 109,263
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.31
• Price to Sales (P/S): 40.66
• P/FCF Ratio: -3.78
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: 13.00p ▼(-16.13% Downside)

The score is held down primarily by weak financial performance (losses and persistent cash burn) and bearish technicals (below major moving averages with negative MACD). Valuation provides limited support due to negative earnings, partially offset by generally positive corporate updates and successful fundraising activity.

Positive Factors

University-linked commercialization model

Frontier's core model gives durable access to academic IP and repeat deal flow from university tech‑transfer ecosystems. Structural access to early‑stage inventions supports a steady pipeline of investable spinouts, underpinning long‑term value creation despite outcome lumpiness.

Meaningful equity base provides cushion

A substantial equity base relative to assets gives the group financial latitude to support portfolio companies and absorb continued operating losses. This balance sheet strength provides a multi‑period buffer for commercialization timelines and reduces immediate insolvency risk while exits are pursued.

Recent fundraisings and director alignment

Successful raises and directors buying in are structurally positive: they extend the runway for portfolio support and signal management alignment with shareholders. Ongoing ability to attract capital and stakeholder commitment supports execution of long‑dated commercialization plans.

Negative Factors

Persistent negative operating cash flow

Consistent operating and free cash flow deficits mean the group relies on financing to fund operations and portfolio support. Over months this erodes flexibility, increases dilution or debt dependence, and constrains the company's ability to self‑fund growth or weather delayed exit timings.

Deteriorated profitability and volatile revenue

Volatile, low revenue and a sharply negative net margin limit the firm’s ability to generate recurring earnings from operations. This undermines sustainable cash generation and makes long‑term returns dependent on successful, uncertain liquidity events from portfolio exits.

Increased leverage after years of no debt

The shift to a debt‑bearing capital structure raises fixed obligations and reduces financial flexibility. With weak cash generation and recurring losses, higher leverage increases refinancing and solvency risk and may limit the company's capacity to back capital‑intensive or long‑duration commercialization projects.

Frontier IP Business Overview & Revenue Model

Company Description

Frontier IP Group Plc, through its subsidiaries, identifies and evaluates commercialization of intellectual property generated by academics, universities, and other partners in the United Kingdom. It also provides investment advisory and marketing services. The company was incorporated in 2007 and is based in London, the United Kingdom.

How the Company Makes Money

Frontier IP makes money primarily by taking equity stakes in spin-out companies that emerge from its university and research institution partnerships. The company provides these spin-outs with essential support in areas such as business development, strategic planning, and fundraising in exchange for equity. Revenue is generated when these companies succeed and Frontier IP can realize returns on its equity stakes through sales or licensing deals. Additionally, the company may earn fees for advisory services provided to its portfolio companies. The success of Frontier IP's revenue model heavily depends on the performance of its portfolio companies and the strength of its partnerships with academic institutions.

Frontier IP Financial Statement Overview

Summary

Frontier IP faces significant challenges across its financial statements. The income statement shows declining revenues and negative margins, indicating profitability issues. The balance sheet is robust with no debt, but declining asset values raise concerns. Cash flow remains a concern with persistent negative free cash flow, pointing to operational struggles. The company needs to address its revenue and cost structure to improve financial health.

Income Statement

The company has experienced a decline in revenue growth, with a decrease from 2023 to 2024. Margins are largely negative, indicating operational challenges. The gross profit margin is negative, highlighting cost issues. The net profit margin has improved slightly from 2023 to 2024, but remains negative, indicating ongoing profitability challenges.

Balance Sheet

The balance sheet is strong in terms of equity, with no debt, indicating a conservative financial structure. The equity ratio is high, reflecting a stable asset base supported by equity. However, the decline in total assets and stockholders' equity over time suggests potential asset management issues.

Cash Flow

The company shows improved free cash flow from 2023 to 2024, but it remains negative, indicating cash outflows. The operating cash flow remains negative, showing the company is not generating sufficient cash from operations. The free cash flow to net income ratio is unfavorable, highlighting cash generation issues relative to reported earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	325.00K	325.00K	358.00K	372.00K	329.00K	362.00K
Gross Profit	291.00K	291.00K	-1.42M	-1.15M	-1.39M	-1.17M
EBITDA	-6.25M	-6.25M	-3.33M	-2.89M	-3.04M	-2.07M
Net Income	-6.34M	-6.34M	-1.13M	-3.24M	10.23M	9.57M
Balance Sheet
Total Assets	54.41M	54.41M	45.09M	45.99M	50.08M	38.87M
Cash, Cash Equivalents and Short-Term Investments	2.58M	2.58M	2.30M	4.60M	4.37M	1.99M
Total Debt	12.06M	12.06M	0.00	0.00	0.00	0.00
Total Liabilities	12.40M	12.40M	315.00K	452.00K	1.39M	445.00K
Stockholders Equity	42.00M	42.00M	44.77M	45.54M	48.70M	38.42M
Cash Flow
Free Cash Flow	-3.50M	-3.50M	-2.83M	-3.26M	-3.01M	-1.48M
Operating Cash Flow	-3.46M	-3.46M	-2.81M	-3.25M	-3.01M	-1.47M
Investing Cash Flow	420.00K	420.00K	370.00K	3.38M	5.38M	-1.69M
Financing Cash Flow	3.33M	3.33M	136.00K	98.00K	0.00	2.18M

Frontier IP Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 15.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:FIPP, the sentiment is Negative. The current price of 15.5 is above the 20-day moving average (MA) of 15.31, below the 50-day MA of 17.43, and below the 200-day MA of 19.62, indicating a bearish trend. The MACD of -0.85 indicates Positive momentum. The RSI at 15.13 is Positive, neither overbought nor oversold. The STOCH value of 20.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:FIPP.

Frontier IP Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
MERC	67 Neutral	£116.20M	34.87	1.79%	3.29%	-9.37%	―
GROW	63 Neutral	£924.00M	8.57	8.92%	―	11.00%	―
BUR	59 Neutral	£1.60B	24.91	3.62%	1.22%	-37.43%	-67.39%
EMVC	52 Neutral	£16.92M	-6.32	-14.80%	―	30.40%	23.48%
IPO	50 Neutral	£500.02M	-3.94	-14.23%	―	―	33.10%
FIPP	43 Neutral	£10.21M	-1.39	-14.62%	―	-9.22%	-386.93%

Frontier IP Corporate Events

Frontier IP’s Vaccine Group Scores Strong Trial Results for Pig Disease Vaccine

Frontier IP portfolio company The Vaccine Group has reported that its vaccine candidate against the zoonotic pig disease Streptococcus suis outperformed a leading commercial rival in challenge trials run by UK contract research organisation Moredun Scientific. The study showed that the firm’s bovine herpesvirus (BoHV-4) delivery platform is effective beyond cattle, works against both bacterial and viral pathogens, and can protect against multiple S. suis serotypes, reinforcing the broad applicability of its vaccine technology. The S. suis programme, which has benefited from collaborations in China and funding from Innovate UK, sits alongside a separate partnership with Spanish animal health group Syva on another S. suis vaccine, while The Vaccine Group is also in discussions with major animal health companies over commercial development of its bovine respiratory syncytial virus candidates for cattle, potentially strengthening Frontier IP’s position in the animal health innovation market.

The most recent analyst rating on (GB:FIPP) stock is a Sell with a £13.00 price target. To see the full list of analyst forecasts on Frontier IP stock, see the GB:FIPP Stock Forecast page.

Frontier IP Confirms Total Voting Rights at 75.6 Million Shares

Frontier IP Group plc has confirmed that its issued share capital consists of 75,638,239 ordinary shares of 10 pence each, with one voting right per share and no shares held in treasury, setting the total number of voting rights at the same figure. This updated capital and voting rights position provides the reference denominator for shareholders assessing whether they must disclose holdings or changes in interests under UK financial transparency rules, ensuring clarity for investors and regulators on the company’s current equity structure.

The most recent analyst rating on (GB:FIPP) stock is a Hold with a £15.00 price target. To see the full list of analyst forecasts on Frontier IP stock, see the GB:FIPP Stock Forecast page.

Frontier IP Wins Shareholder Backing for All Resolutions at AGM

Frontier IP Group plc reported that all resolutions at its annual general meeting held on 31 December 2025 were duly passed, including approval of the audited accounts and directors’ remuneration for the year ended 30 June 2025. Shareholders backed the reappointment of all existing directors and the company’s auditor, and renewed authorities for the board to allot shares, disapply pre-emption rights in certain circumstances and make on-market share repurchases, signalling continued shareholder support for the current governance, capital structure flexibility and growth strategy.

The most recent analyst rating on (GB:FIPP) stock is a Hold with a £15.00 price target. To see the full list of analyst forecasts on Frontier IP stock, see the GB:FIPP Stock Forecast page.

Frontier IP Directors Boost Stakes Following Fundraising Completion

Frontier IP Group plc has disclosed updated director shareholdings following the completion of a recent fundraising and retail offer, confirming the enlarged stakes held by its board members in the company’s ordinary shares. Chief executive Neil Crabb now holds 4.58 million shares, representing 6.05% of the enlarged share capital, while other executive and non-executive directors have also increased their holdings through participation in the subscription at 15.5 pence per share, signalling board-level confidence and further aligning management interests with those of shareholders.

Frontier IP Raises £1.04m After Oversubscribed Retail Offer

Frontier IP Group has successfully completed an oversubscribed retail offer, raising £174,117 through the issue of 1,123,338 new shares at 15.5 pence each, as part of a wider fundraising that has conditionally generated approximately £1.04 million in gross proceeds. The additional capital, raised via a combination of placing, subscription and retail offer, will expand the company’s equity base to 75,638,239 ordinary shares, reinforcing its financial position as it pursues its IP commercialisation strategy, while the forthcoming admission of the new shares to trading on AIM on 24 December 2025 will broaden the shareholder base and may alter voting dynamics for existing investors under UK disclosure rules.

Frontier IP Portfolio Firm Dekiln Secures £3m Green Future Fellowship Funding

Frontier IP Group has highlighted a major boost for its portfolio company Dekiln Limited, after chief executive Dr Aled Roberts was named one of the Royal Academy of Engineering’s inaugural Green Future Fellows, bringing £3 million of funding to scale the firm’s kiln-free tile technology to industrial production. Dekiln, a Manchester-based clean-tech company that produces low-carbon, high-recycled-content tiles without energy-intensive kilns, plans to use the funds to build a pilot plant capable of producing up to 1,000m² of tiles per day in partnership with UK industrial partners, following a £693,000 equity raise in 2024 and its first commercial installation. The backing from the Royal Academy, part of a £39 million package for 13 fellows under a government-supported programme, is seen by Frontier IP as strong validation of Dekiln’s technology and is expected to accelerate the company’s scale-up, potentially enhancing Frontier IP’s portfolio value and reinforcing its positioning in climate-focused, resource-efficient industrial innovation.

Frontier IP Raises £870,000 in Funding through Placing and Subscription

Frontier IP Group plc has successfully raised approximately £870,000 through a combination of a share Placing and Subscription, with an additional Retail Offer expected to generate up to £174,117. This funding round is expected to bolster the company’s operational capabilities and further enhance its role in developing and commercializing intellectual property, reinforcing its position in the market.

Frontier IP Launches Retail Share Offer to Boost Capital

Frontier IP Group plc has announced a conditional retail offer of new ordinary shares at a discounted price of 15.5 pence per share, available through RetailBook’s partner network. The offer aims to raise funds to support the company’s working capital and portfolio companies, with a minimum subscription of £250 per investor. The retail offer is part of a broader fundraising effort, including a placing and subscription by directors, to address the company’s financial needs and explore further funding opportunities in 2026. The company plans to review its cost base to enhance operational efficiency while maintaining growth momentum.

Frontier IP Group Announces £870,000 Fundraising to Bolster Portfolio Growth

Frontier IP Group plc announced a proposed equity fundraising to raise approximately £870,000 through a combination of placing new ordinary shares and a subscription by the company’s directors. The fundraising aims to strengthen the company’s financial position amidst a challenging market environment, with the proceeds expected to support the continued development and commercialization of its portfolio companies. Despite recent financial setbacks, including unrealized losses and a reduced net asset value, the company remains optimistic about the progress and potential of its portfolio, which includes promising developments in sectors such as AI, defense, and energy conversion.

Alusid Secures £500,000 in Pre-IPO Funding to Expand Sustainable Tile Operations

Frontier IP Group, which focuses on commercializing intellectual property, announced that its portfolio company Alusid Limited has raised £500,000 in a pre-IPO funding round, valuing the company at £10 million. The funds will be used to prepare for a potential IPO on AIM, expand product ranges, and develop Alusid’s low carbon tile manufacturing technology. Alusid is also broadening its market by developing new product categories and expanding its international distribution network, with growing demand for its sustainable tiles in both retail and commercial sectors.

Frontier IP Releases 2025 Annual Report and Announces AGM

Frontier IP Group plc has announced that its 2025 Annual Report and Accounts are now accessible on its website, with hard copies distributed to eligible shareholders. The company’s Annual General Meeting is scheduled for 31 December 2025 in Edinburgh, marking a significant event for stakeholders to discuss the company’s progress and future strategies.

Frontier IP Group Reports Stable Equity Amid Strategic Expansion

Frontier IP Group plc reported its financial results for the year ending June 30, 2025, revealing a stable equity portfolio value but a significant reduction in its debt portfolio due to conversions and losses. The company experienced a substantial loss before tax driven by unrealized losses and operating expenses, despite raising £3.6 million for working capital and portfolio support. The strategic partnership with Abstract Mid-Tech Limited to create an innovation hub in Cambridge is expected to strengthen Frontier IP’s presence in the UK’s innovation sector and potentially generate positive cash flow. Several portfolio companies made significant progress, including successful funding rounds and international agreements, indicating strong technical and commercial advancements despite a challenging funding environment.

Alusid Expands European Reach with Swedish Distribution Deal

Alusid Limited, a portfolio company of Frontier IP Group, has signed an exclusive distribution agreement with Kakelspecialisten AB, a leading Swedish tile distributor and subsidiary of Saint-Gobain. This partnership marks Alusid’s third international agreement, enhancing its European distribution network and reflecting growing global interest in its sustainable tile products. The agreement grants Kakelspecialisten exclusive rights to distribute Alusid’s tiles in Sweden for 24 months, with non-exclusive rights for distribution outside Sweden. This collaboration aligns with Kakelspecialisten’s sustainability goals and strengthens Alusid’s position in the low-carbon tile market, potentially paving the way for further growth and an IPO.

Frontier IP Announces CFO Departure and Succession Plans

Frontier IP Group Plc announced the departure of its Chief Financial Officer, Jo Stent, who is leaving to join a private equity-backed financial services provider. Stent will step down by April 2026, after overseeing the company’s annual and interim results. The company has begun the search for a new CFO, with updates to follow. CEO Neil Crabb expressed gratitude for Stent’s contributions, highlighting an amicable departure.

Frontier IP’s Portfolio Company Achieves Breakthrough in Livestock Vaccine Trials

Frontier IP Group plc announced that its portfolio company, The Vaccine Group, has achieved significant success in animal trials with two vaccine candidates targeting bovine respiratory syncytial virus (BRSV). These vaccines, developed using a novel bovine herpesvirus delivery platform, have shown to effectively prevent BRSV in cattle, overcoming limitations of current vaccines that are ineffective in the presence of maternal antibodies. This breakthrough represents a major milestone for The Vaccine Group and positions its technology as a potential market leader in livestock disease prevention, with plans to engage strategic partners for further development.

Amprologix Secures £740,000 to Advance Novel Antibiotics

Amprologix, a portfolio company of Frontier IP, has raised £740,000 in a pre-Series A funding round to advance the development of its novel antibiotics aimed at combating antimicrobial-resistant diseases. The funds will be used to complete pre-clinical development of its lead candidate, epidermicin NI01, which targets Methicillin-resistant Staphylococcus aureus (MRSA), in preparation for Phase I human clinical trials in 2026. This investment, supported by Plutus Investment Group and others, positions Amprologix for a Series A funding round and highlights the urgent need for new therapies to address rising drug-resistant infections, a significant global health threat identified by the World Health Organization.